Qurate Retail Inc Series A vs Twist Bioscience Corp — how do they compare? Qurate Retail Inc Series A trades at $0.04 (market cap $653.75K), while Twist Bioscience Corp trades at $93.82 (market cap $5.97B). The key difference: Twist Bioscience Corp is far larger — about 9131.9× Qurate Retail Inc Series A's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Qurate Retail Inc Series A nearer its low. Which is the better fit depends on your goals.
| QVCAQ | TWST | |
|---|---|---|
Market Cap | $653.75K | $5.97B |
Sector | Consumer Cyclical | Health |
52-Week High | $15.03 | $102.88 |
52-Week Low | $0.05 | $24.16 |
Enterprise Value | $4.73B | $5.89B |
Trailing returns across standard periods
Latest headlines on both assets
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →